KLRK1 and neoplasm: Radiation increases the expression of NKG2D ligands in several human tumor cell lines, suggesting that NK cell-based therapies should be developed and explored in clinical trials (Sayitoglu et al., 2020; Wang J. et al., 2021; Khan et al., 2021).